Cost-Effectiveness of Community-Based Tobacco Dependence Treatment Interventions: Initial Findings of a Systematic Review

Details

• Journal Article:
  Preventing Chronic Disease (PCD)
• Personal Author:
  Reisinger, Sarah A. ; Kamel, Sahar ; Seiber, Eric ; Klein, Elizabeth G. ; Paskett, Electra D. ; Wewers, Mary Ellen
• Description:
  Introduction
  
  Scientific literature evaluating the cost-effectiveness of tobacco dependence treatment programs delivered in community-based settings is scant, which limits evidence-based tobacco control decisions. The aim of this review was to systematically assess the cost-effectiveness and quality of the economic evaluations of community-based tobacco dependence treatment interventions conducted as randomized controlled trials in the United States.
  
  Methods
  
  We searched 8 electronic databases and gray literature from their beginning to February 2018. Inclusion criteria were economic evaluations of community-based tobacco dependence treatments conducted as randomized controlled trials in the United States. Two independent researchers extracted data on study design and outcomes. Study quality was assessed by using Drummond and Jefferson’s economic evaluations checklist. Nine of 3,840 publications were eligible for inclusion. Heterogeneity precluded formal meta-analyses. We synthesized a qualitative narrative of outcomes.
  
  Results
  
  All 9 studies used cost-effectiveness analysis and a payer/provider/program perspective, but several study components, such as abstinence measures, were heterogeneous. Study participants were predominantly English speaking, middle aged, white, motivated to quit, and highly nicotine dependent. Overall, the economic evaluations met most of Drummond and Jefferson’s recommendations; however, some studies provided limited details. All studies had a cost per quit at or below $2,040 or an incremental cost-effectiveness ratio (ICER) at or below $3,781. When we considered biochemical verification, sensitivity analysis, and subgroups, the costs per quit were less than $2,050 or the ICERs were less than $6,800.
  
  Conclusion
  
  All community-based interventions included in this review were cost-effective. When economic evaluation results are extrapolated to future savings, the low cost per quit or ICER indicates that the cost-effectiveness of community-based tobacco dependence treatments is similar to the cost-effectiveness of clinic-based programs and that community-based interventions are a valuable approach to tobacco control. Additional research that more fully characterizes the cost-effectiveness of community-based tobacco dependence treatments is needed to inform future decisions in tobacco control policy.
  
  
• Subjects:
  Systematic Review
• Source:
  Prev Chronic Dis. 16
• ISSN:
  1545-1151
• Pubmed ID:
  31831106
• Pubmed Central ID:
  PMC6936666
• Document Type:
  Journal Article
• Volume:
  16
• Collection(s):
  Preventing Chronic Disease
• Main Document Checksum:
  urn:sha-512:f9dc157b2f33fc1b84f76d33b84765b9022896e882d2348f4f2ab0939e2542bfa919e143fc0f979a61cf6fccc3bc3d915b3f6f89ed36c8af087ead5714f6bfc4
• Download URL:
  https://stacks.cdc.gov/view/cdc/84192/cdc_84192_DS1.pdf
• File Type:
  [PDF - 601.07 KB ]